menu
    • menu

    Company profile for Cambrex Corporation

    Evonik

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. With over 35 years of API development and manufacturing expertise, a growing team of more than 1,200 experts and a strong presence in the USA and Europe, we are tried and trusted across branded and generic API markets. We put all of our energy and experience into bein...
    Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. With over 35 years of API development and manufacturing expertise, a growing team of more than 1,200 experts and a strong presence in the USA and Europe, we are tried and trusted across branded and generic API markets. We put all of our energy and experience into being your partner of choice. We create value for customers through manufacturing excellence, reliable quality and innovative science. Our people are the experts that our customers enjoy working with.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cambrex CorporationUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    One Meadowlands Plaza, East Rutherford, NJ 07073
    Telephone
    Telephone
    +1 201-804-3000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cambrex.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/13418/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/cambrex

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI North America

    Not Confirmed

    envelop Contact Supplier

    CPhI North America

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Our unmatched efficiency and track record of faster DMF filings give our customers a critical competitive advantage”

    “Our unmatched efficiency and track record of faster DMF filings give our customers a critical competitive advantage”

    This week, SpeakPharma interviews Pete Werth III, the new president of ChemWerth, a company that has been at the forefront of the generic pharmaceutical industry for over four decades. He shares his vision for ChemWerth, which includes his commitment to strengthening global manufacturing relationships, and enhancing supply chain resilience. Additionally, he highlights the key aspects of a successful drug master file (DMF). HIGHLIGHTS// Pete Werth III, the new president of ChemWerth/ vision for ChemWerth/ commitment to strengthening global manufacturing relationships/ key aspects of a successful drug master file Your father, Peter J. Werth, is recognized as one of the founders of the generic pharmaceutical industry, having built ChemWerth from the ground up over four decades ago. How do you view his legacy? As you take the helm, what key lessons or principles from his leadership do you intend to carry forward? My father, Peter J. Werth, is a true pioneer in the generic pharmaceutical industry. Over his 42‐year tenure, he not only built ChemWerth from a humble garage startup into a global leader in generic API development but also established standards that many in our industry now take for granted. Under his leadership, we filed our very first DMF in 1987 and have since achieved more than 500 DMF filings. With an average review cycle of just 0.79, we have been far outperforming the industry average of 2.5 cycles. His focus on quality, regulatory excellence, and a relentless commitment to customers’ success set the foundation for our reputation as a trusted supplier of over 500 APIs sourced from more than 30 cGMP-certified facilities worldwide. Equally inspiring is his dedication to nurture long-term, mutually beneficial relationships with manufacturing partners across the US, Europe, India, and China, as well as his passion for giving back to the community through philanthropic initiatives. As I take the helm, I intend to build on his guiding principles — sustaining our high standards of quality and compliance while pursuing innovation in regulatory strategy, diversifying our supply chain, and embracing new technologies and approaches to remain competitive in an evolving market. I will also strive to continue his legacy of mentorship, ensuring that our company culture remains rooted in integrity and diligence, with an unyielding focus on making safe, affordable medicines available worldwide. HIGHLIGHTS// trusted supplier of over 500 APIs/ 30 cGMP-certified facilities worldwide/ embracing new technologies and approaches to remain competitive What are your top priorities as the new president of ChemWerth? How do you plan to strengthen and expand relationships with manufacturers worldwide? My immediate priorities as the new president are twofold: to enhance the value we deliver to our customers and, to deepen our relationships with our manufacturing partners worldwide. We will further diversify our supply chain and broaden our product portfolio. Our expansion plans include upgrading equipment, and hiring additional highly skilled scientists, engineers, and GMP auditors. We will also leverage our proprietary product selection and regulatory submission processes. These processes help us get the regulatory filing right the first time, and allows us to be approved 44 percent faster than the industry average. This helps our customers gain a competitive edge in the market. In essence, by strengthening operational excellence and expanding our global network, we intend to continue the company’s long-standing commitment to customer success and process innovation. We plan to reinforce our long-standing relationships with our manufacturers — especially those in strategic markets like China and India — by helping our partners meet the highest standards of regulatory compliance and current good manufacturing practice (cGMP) quality. This balanced approach of strengthening existing partnerships while pioneering new ones is key to maintaining and growing our competitive edge. HIGHLIGHTS// diversify our supply chain and broaden our product portfolio/ commitment to customer success and process innovation/ filings approved 44 percent faster than the industry average When ChemWerth last spoke to PharmaCompass, there was a mention of investing millions of dollars in expanding manufacturing partnerships in China and India. Can you elaborate on the success of these partnerships, and how have they contributed to ChemWerth’s overall growth? Our strategic, multimillion-dollar investments in manufacturing partnerships are a cornerstone of our growth strategy. Over the past few years, these joint ventures have proven their worth by diversifying our supply base and mitigating the risk of global supply chain disruptions — a lesson that became all too clear during the Covid-19 pandemic. These investments are already paying dividends. They help us support manufacturers producing steroids, hormones, veterinary products, and large-volume APIs, while also accelerating the development of small-molecule inhibitors and new generic APIs. We have ensured that our partners are equipped with the latest equipment and trained personnel to meet cGMP standards. By partnering with facilities in these markets, we now have access to state-of-the-art production capabilities that enable us to produce a wider range of APIs at competitive costs. The success of these partnerships is evident in our ability to consistently file DMFs rapidly — often on the first cycle — and deliver affordable, high-quality medicines to patients worldwide. This supports our clients’ growth trajectory and has helped us expand into new markets. This strategy has reinforced our global footprint — supporting our presence in 38 countries with over 100 products — and positioned us well to capitalize on a global generic drug market projected to grow at a compounded annual growth rate of 5.4 percent from 2022 to 2030, to reach a size of US$ 671 billion by 2030. HIGHLIGHTS// strategic multimillion-dollar investments/ support manufacturers producing steroid, hormone, veterinary products/ development of small-molecule inhibitors and new generic APIs/ ensured partners are equipped with the latest equipment and trained personnel ChemWerth has an impressive track record, and an over 40-year relationship with the US Food and Drug Administration (FDA). What are the key aspects of a successful DMF? Are there specific challenges manufacturers face in preparing DMFs, and how does ChemWerth help them overcome these hurdles? ChemWerth’s record of filing over 500 DMFs in 38 countries reflects our commitment to excellence in regulatory compliance and quality management. A successful DMF is built on comprehensive documentation that rigorously follows cGMP guidelines, robust analytical validation, and detailed tracking of every step. Every DMF we file meticulously details the entire manufacturing process — from raw material acquisition to final batch production. This comprehensive approach ensures that our submissions meet the rigorous quality, safety, and efficacy standards expected by the FDA. Our team stays continuously updated on the evolving guidelines and protocols, which allows us to file DMFs that align with current FDA practices. We recognize that many manufacturers face challenges such as complex regulatory requirements, lengthy review cycles, and the need for precise coordination between various production stages. ChemWerth helps them overcome these hurdles by offering end-to-end regulatory support, detailed internal audits, and continuous training on cGMP and FDA requirements. Our efficiency is a critical competitive advantage. By receiving approvals 44 percent faster than the industry average, we help our customers get their products to market faster, resulting in larger market share and increased profits. HIGHLIGHTS// over 500 DMFs in 38 countries/ robust analytical validation/ end-to-end regulatory support What is your vision for ChemWerth over the next few years? How do you plan to navigate the challenges and opportunities in the generic pharmaceutical industry? I plan to continue to add value for our customers, and look for innovative ways to compete in today’s generic pharmaceutical landscape. At ChemWerth, our vision for the future is rooted in both our proud legacy and our relentless drive for innovation. We will further diversify our supply chain and expand our product portfolio. We have begun leveraging our expertise to supply APIs for biosimilars and new drug applications (NDAs), while maintaining our reputation for rapid regulatory approvals. With unwavering determination, we uphold our “First to Quality. Fast to Market.” approach — delivering high-quality APIs to customers worldwide while leveraging our expertise to give them a competitive edge in their markets. HIGHLIGHTS// supply APIs for biosimilars and NDAs/ give customers a competitive edge in their markets 

    Impressions: 947

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage

    Radio Compass
    12 Mar 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    Top Pharma Companies & Drugs in 2024: Merck’s Keytruda maintains top spot as Novo’s semaglutide nips at its heels

    Top Pharma Companies & Drugs in 2024: Merck’s Keytruda maintains top spot as Novo’s semaglutide nips at its heels

    In 2024, Big Pharma players consolidated and maintained their dominance, even as innovation continued to reshape the pharmaceutical landscape. The primary change last year was the meteoric rise of glucagon-like peptide-1 (GLP-1) receptor agonists that treat diabetes and help in weight loss.Amongst drugmakers, Pfizer retained its numero uno spot with an impressive US$ 63.6 billion in prescription drug sales (up 7 percent from US$ 59.56 billion reported in 2023), despite ever-shrinking Comirnaty sales, which settled at US$ 5.35 billion in 2024 (from US$ 11.22 billion in 2023).Merck secured the second position with revenues of US$ 57.4 billion, a growth of 7 percent over 2023. This performance was predominantly fueled by Keytruda, which now accounts for more than half of Merck’s total pharmaceutical revenue. Johnson & Johnson came a close third with US$ 57 billion in prescription drug sales (up from US$ 54.76 billion in 2023).AbbVie held the fourth position with US$ 56.33 billion in sales, achieving 3.7 percent growth despite the ongoing erosion of Humira revenue. This flagship immunology drug saw sales plummet 37.6 percent to approximately US$ 9 billion, a US$ 5.4 billion reduction compared to 2023. Humira’s loss was offset by AbbVie’s newer immunology assets, particularly Skyrizi and Rinvoq, both of which demonstrated exceptional growth trajectories. View Our Interactive Dashboard on Top Drugs in 2024 by Sales (Free Excel Available)European giants Astra, Roche, Novartis, Sanofi round out top 10 list; Novo, Lilly see astounding growthWhile the top four positions were dominated by American drugmakers, European giants dominated the lower half of the top 10 list.AstraZeneca secured the fifth spot with US$ 54.1 billion in sales, thereby posting impressive growth of 18.1 percent over 2023. Roche claimed the sixth position with US$ 50.9 billion in sales while Novartis ranked seventh — with sales of US$ 50.3 billion. Novartis' impressive 10.8 percent sales growth is attributed to its innovative medicines portfolio. Oncology therapies remained a cornerstone for both these Swiss drugmakers.Bristol Myers Squibb (BMS) secured eighth position with revenues of US$ 48.3 billion, representing 7.3 percent growth over the previous year. At US$ 45 billion, Eli Lilly posted 32 percent revenue growth last year. Its GLP-1 drug Mounjaro helped Lilly move up from the tenth in 2023 to the ninth spot last year.Sanofi landed the tenth position with US$ 42.6 billion in sales, propelled largely by the expanding indications of Dupixent. The French multinational has increasingly focused on this immunology blockbuster, while also garnering more sales from its vaccine and rare disease portfolios.Novo Nordisk merits a mention as it posted an incredible 26 percent year-on-year growth. It retained its eleventh spot with US$ 40.25 billion in sales. Novo’s growth was driven almost exclusively by the extraordinary success of its GLP-1 receptor agonist portfolio. View Our Interactive Dashboard on Top Drugs in 2024 by Sales (Free Excel Available)       Merck’s Keytruda retains throne with US$ 29.5 bn in sales, as Novo’s semaglutide nips at its heelsMoving on to drugs, Merck’s Keytruda (pembrolizumab) solidified its position as the world’s top-selling pharmaceutical product with sales exceeding US$ 29.5 billion and year-on-year growth of 17.88 percent (US$ 4.5 billion). This remarkable performance was driven by steady sales growth across more than 40 indications in the US. In 2024 alone, Keytruda secured four new approvals from the US Food and Drug Administration (FDA).However, Novo Nordisk’s semaglutide sales (Ozempic, Wegovy and Rybelsus) gave Keytruda a run for its money. Across the three blockbuster drugs, semaglutide earned the Danish drugmaker around US$ 28 billion — i.e. a year-on-year increase of 38 percent.Novo’s Ozempic (semaglutide) reached over US$ 16.7 billion in sales — a 20 percent increase from 2023. Originally approved in 2017 to improve glycemic control, Ozempic bagged additional approvals in 2020, and in January 2025. It is now approved to reduce the risk of major cardiovascular events, as well as to reduce cardiovascular risk and to lower the likelihood of chronic kidney disease in type 2 diabetes patients.Sales of Wegovy (semaglutide), the other blockbuster GLP-1 drug from Novo, grew by a whopping 85.7 percent to over US$ 8 billion.Sanofi and Regeneron’s Dupixent (dupilumab) secured the number three spot with sales of US$ 13.6 billion, representing an impressive 17.2 percent year-on-year growth. In 2024, Dupixent received three new approvals and one label update. Notably, it became the first-ever biologic medicine approved for patients with chronic obstructive pulmonary disease (COPD). View Our Interactive Dashboard on Top Drugs in 2024 by Sales (Free Excel Available) AbbVie’s post-Humira strategy pays off as Skyrizi surges 51%; Lilly’s Mounjaro posts 124% growthGilead Sciences’ HIV treatment Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) showed robust growth of 13.27 percent, touching sales of US$ 13.42 billion in 2024 and emerging as the fourth largest selling drug. Biktarvy now commands over 50 percent of the US HIV treatment market. Unlike many other drugs on this list, Biktarvy faces no immediate patent challenges, with key protections expected to remain intact until 2033.BMS and Pfizer’s anticoagulant Eliquis (apixaban) claimed the fifth position with US$ 13.33 billion in sales, representing a 9.21 percent year-on-year increase. AbbVie’s Skyrizi (risankizumab) emerged as one of the fastest-growing assets with a 50.95 percent year-on-year increase, generating US$ 11.71 billion in 2024 sales, thereby surpassing Humira’s (adalimumab) diminished sales.This impressive performance, combined with Rinvoq’s (upadacitinib) growth, has prompted  AbbVie to raise its long-term outlook for these products. The company now expects combined Skyrizi and Rinvoq revenues to exceed US$ 31 billion by 2027, with Skyrizi alone projected to generate over US$ 20 billion.Johnson & Johnson’s Darzalex (daratumumab) claimed the seventh position with US$ 11.67 billion in sales, representing 19.77 percent growth over 2023.Lilly’s Mounjaro (tirzepatide) demonstrated dramatic growth with sales increasing 123.51 percent to US$ 11.54 billion. This performance was complemented by Zepbound (tirzepatide, for weight loss), which contributed US$ 4.9 billion to Lilly’s revenue. By the end of 2024, Mounjaro received FDA approval for a new indication in obstructive sleep apnea (OSA), becoming the first and only prescription medicine for moderate-to-severe OSA in adults with obesity.Stelara (ustekinumab) ranked ninth, bringing J&J sales of US$ 10.36 billion, showing a modest decline of 4.91 percent from its 2023 sales.Vertex’s triple-combination therapy Trikafta (elexacaftor/tezacaftor/ivacaftor) for treating cystic fibrosis rounded out the top ten list with sales of US$ 10.2 billion, up 14 percent from the previous year. View Our Interactive Dashboard on Top Drugs in 2024 by Sales (Free Excel Available) Our viewIn 2024, transformative therapies like GLP-1 receptor agonists drove growth in the pharmaceutical industry. This year, we expect GLP-1 drugs to dethrone Keytruda from the number one spot. Along with novel immunology agents, we expect GLP-1 drugs to realign the pharmaceutical market.  
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 2006

    https://www.pharmacompass.com/radio-compass-blog/top-pharma-companies-drugs-in-2024-merck-s-keytruda-maintains-top-spot-as-novo-s-semaglutide-nips-at-its-heels

    #PharmaFlow by PHARMACOMPASS
    24 Apr 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Cambrex Partners with Lilly to Support Biotech Manufacturing
    Cambrex Partners with Lilly to Support Biotech Manufacturing

    05 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cambrex-announces-strategic-agreement-with-lilly-to-support-biotech-collaborator-manufacturing-302323176.html

    PR NEWSWIRE
    05 Dec 2024
    Share Share
    Cambrex Opens New Stability Storage Facility In North Carolina
    Cambrex Opens New Stability Storage Facility In North Carolina

    17 Oct 2024

    // PRESS RELEASE

    https://www.cambrex.com/news/cambrex-opens-new-stability-storage-facility-in-durham-north-carolina/

    PRESS RELEASE
    17 Oct 2024
    Share Share
    Atinary Tech Announces Collaboration with Snapdragon Chemistry
    Atinary Tech Announces Collaboration with Snapdragon Chemistry

    26 Sep 2024

    // PRESS RELEASE

    https://www.cambrex.com/news/atinary-technologies-announces-strategic-collaboration-with-snapdragon-chemistry-a-cambrex-company/

    PRESS RELEASE
    26 Sep 2024
    Share Share
    Cambrex Announces New Liquid-Phase Peptide Synthesis Technology
    Cambrex Announces New Liquid-Phase Peptide Synthesis Technology

    19 Sep 2024

    // PRESS RELEASE

    https://www.cambrex.com/news/cambrex-announces-new-liquid-phase-peptide-synthesis-manufacturing-technology/

    PRESS RELEASE
    19 Sep 2024
    Share Share
    Cambrex Expands Stability Storage With New Facility In Durham, North Carolina
    Cambrex Expands Stability Storage With New Facility In Durham, North Carolina

    08 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cambrex-to-expand-stability-storage-business-with-new-facility-in-durham-north-carolina-302190242.html

    PR NEWSWIRE
    08 Jul 2024
    Share Share
    Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan
    Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan

    18 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cambrex-nears-completion-of-5-year-100-million-dollar-investment-plan-one-year-ahead-of-schedule-302090916.html

    PR NEWSWIRE
    18 Mar 2024
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Amiodarone Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Cophex
    Not Confirmed
    arrow

    Amiodarone Hydrochloride

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2016-07-15

    Pay. Date : 2016-06-17

    DMF Number : 3505

    Submission : 1979-04-11

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2005-127 - Rev 02

    Issue Date : 2017-04-04

    Type : Chemical

    Substance Number : 803

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 218MF10853

    Registrant's Address : Via Curiel 34, 20067 Paulo, Milano, ITALY

    Initial Date of Registration : 2006-10-20

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 12828-0018

    Start Marketing Date : 1996-10-16

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Bupivacaine Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Cophex
    Not Confirmed
    arrow

    Bupivacaine Hydrochloride

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2019-10-18

    Pay. Date : 2019-10-15

    DMF Number : 5984

    Submission : 1985-08-27

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2011-254 - Rev 00

    Issue Date : 2019-01-31

    Type : Chemical

    Substance Number : 541

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 218MF10875

    Registrant's Address : SE-691 85 Karlskoga, SWEDEN

    Initial Date of Registration : 2006-11-10

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 12651-111

    Start Marketing Date : 2016-07-19

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Mitsubishi Tanabe Pharma Korea Co., Ltd.

    Registration Date : 2022-12-15

    Registration Number : 20221215-210-J-1423

    Manufacturer Name : Cambrex Karlskoga AB

    Manufacturer Address : SE-691 85 Karlskoga, Sweden

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Epinephrine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Cophex
    Not Confirmed
    arrow

    Epinephrine

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-11-13

    Pay. Date : 2014-06-13

    DMF Number : 25989

    Submission : 2012-04-13

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2013-266 - Rev 01

    Issue Date : 2023-01-31

    Type : Chemical

    Substance Number : 2303

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 226MF10196

    Registrant's Address : Via Curiel 34, 20067 Paulo, Milano, ITALY

    Initial Date of Registration : 2014-10-27

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 12828-0082

    Start Marketing Date : 2012-08-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Fentanyl

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Cophex
    Not Confirmed
    arrow

    Fentanyl

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-10-18

    Pay. Date : 2013-04-09

    DMF Number : 16872

    Submission : 2003-09-26

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2004-288 - Rev 03

    Issue Date : 2020-05-25

    Type : Chemical

    Substance Number : 1210

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 222MF10279

    Registrant's Address : 1205 11th Street, Charles City, Iowa, U.S. S. A.

    Initial Date of Registration : 2010-12-24

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 59116-2645

    Start Marketing Date : 2018-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Lidocaine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Cophex
    Not Confirmed
    arrow

    Lidocaine

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 19532

    Submission : 2006-04-30

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2011-326 - Rev 00

    Issue Date : 2018-05-17

    Type : Chemical

    Substance Number : 727

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 222MF10045

    Registrant's Address : SE-691 85 Karlskoga, SWEDEN

    Initial Date of Registration : 2010-02-09

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 12651-124

    Start Marketing Date : 2023-10-12

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Lidocaine Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Cophex
    Not Confirmed
    arrow

    Lidocaine Hydrochloride

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2015-10-07

    Pay. Date : 2015-09-29

    DMF Number : 19531

    Submission : 2006-04-30

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2011-325 - Rev 02

    Issue Date : 2021-06-22

    Type : Chemical

    Substance Number : 227

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 218MF10963

    Registrant's Address : SE-691 85 Karlskoga, SWEDEN

    Initial Date of Registration : 2006-12-01

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 12651-113

    Start Marketing Date : 2006-06-30

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Lorazepam

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Cophex
    Not Confirmed
    arrow

    Lorazepam

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2020-09-25

    Pay. Date : 2020-09-21

    DMF Number : 4517

    Submission : 1982-05-04

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2008-049 - Rev 02

    Issue Date : 2022-04-19

    Type : Chemical

    Substance Number : 1121

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 218MF10781

    Registrant's Address : Via Curiel 34, 20067 Paulo, Milano, ITALY

    Initial Date of Registration : 2006-09-22

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 12828-0025

    Start Marketing Date : 1987-03-12

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Mesalazine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Cophex
    Not Confirmed
    arrow

    Mesalazine

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-03-28

    Pay. Date : 2013-03-18

    DMF Number : 5693

    Submission : 1985-01-24

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2004-093 - Rev 03

    Issue Date : 2021-06-11

    Type : Chemical

    Substance Number : 1699

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 220MF10007

    Registrant's Address : SE-691 85 Karlskoga, SWEDEN

    Initial Date of Registration : 2008-01-09

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 12651-582

    Start Marketing Date : 1988-03-21

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Daewoong Pharmaceutical Co., Ltd.

    Registration Date : 2020-06-25

    Registration Number : 20200625-209-J-403

    Manufacturer Name : Cambrex, Karlskoga AB

    Manufacturer Address : Bjorkborn Industriomrade, Karlskoga 69185 Sweden

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Midazolam

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Cophex
    Not Confirmed
    arrow

    Midazolam

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-04-18

    Pay. Date : 2014-04-10

    DMF Number : 12686

    Submission : 1997-10-06

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2006-025 - Rev 03

    Issue Date : 2017-07-28

    Type : Chemical

    Substance Number : 936

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 223MF10029

    Registrant's Address : Via Curiel 34, 20067 Paulo, Milano, ITALY

    Initial Date of Registration : 2011-02-25

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 12828-0069

    Start Marketing Date : 1996-10-03

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Ondansetron Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Cophex
    Not Confirmed
    arrow

    Ondansetron Hydrochloride

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Cophex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2018-10-23

    Pay. Date : 2018-09-13

    DMF Number : 15752

    Submission : 2001-12-05

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2003-130 - Rev 01

    Issue Date : 2011-12-12

    Type : Chemical

    Substance Number : 2016

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 219MF10374

    Registrant's Address : 1205 11th Street, Charles City, Iowa, U.S. S. A.

    Initial Date of Registration : 2007-12-19

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 59116-1850

    Start Marketing Date : 2012-10-26

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Samoh Pharmaceutical Co., Ltd.

    Registration Date : 2013-03-13

    Registration Number : 20130313-47-B-343-17

    Manufacturer Name : Cambrex Charles City, Inc

    Manufacturer Address : 1205 11th st. Charles City, IA 50616, USA

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Services

    Upload your portfolio for free, ask us

    Analytical

    Click here to discover the service providers for Analytical

    API Manufacturing

    Click here to discover the service providers for API Manufacturing

    Drug Product Manufacturing

    Click here to discover the service providers for Drug Product Manufacturing

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    Packaging

    Click here to discover the service providers for Packaging

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Cambrex Profarmaco Milano Srl and get a quotation

    Cambrex Profarmaco Milano Srl is a supplier offers 189 products (APIs, Excipients or Intermediates).

    Find a price of Alprazolam bulk with DMF, CEP, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Amiodarone Hydrochloride bulk with DMF, CEP, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Bupivacaine Hydrochloride bulk with DMF, CEP, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Epinephrine bulk with DMF, CEP, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Fentanyl bulk with DMF, CEP, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Hydrochlorothiazide bulk with DMF, CEP, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Lidocaine bulk with DMF, CEP, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Lidocaine Hydrochloride bulk with DMF, CEP, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Lorazepam bulk with DMF, CEP, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Mesalazine bulk with DMF, CEP, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Midazolam bulk with DMF, CEP, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Ondansetron Hydrochloride bulk with DMF, CEP, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Rivastigmine bulk with DMF, CEP, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Sodium Cromoglicate bulk with DMF, CEP, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Amphetamine bulk with DMF, CEP offered by Cambrex Profarmaco Milano Srl

    Find a price of Aripiprazole bulk with DMF, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Benzoyl Peroxide bulk with DMF, CEP offered by Cambrex Profarmaco Milano Srl

    Find a price of Bisacodyl bulk with DMF, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Chlordiazepoxide bulk with DMF, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Clorazepate Dipotassium bulk with DMF, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Clozapine bulk with DMF, CEP offered by Cambrex Profarmaco Milano Srl

    Find a price of Cysteamine Bitartrate bulk with DMF, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Diazepam bulk with DMF, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Epinephrine Bitartrate bulk with DMF, CEP offered by Cambrex Profarmaco Milano Srl

    Find a price of Estazolam bulk with DMF, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Fentanyl Citrate bulk with DMF, CEP offered by Cambrex Profarmaco Milano Srl

    Find a price of Glibenclamide bulk with DMF, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Lacosamide bulk with DMF, CEP offered by Cambrex Profarmaco Milano Srl

    Find a price of Lormetazepam bulk with DMF, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Mesalazine bulk with DMF, CEP offered by Cambrex Profarmaco Milano Srl

    Find a price of Nicotine bulk with DMF, CEP offered by Cambrex Profarmaco Milano Srl

    Find a price of Norepinephrine Bitartrate bulk with DMF, CEP offered by Cambrex Profarmaco Milano Srl

    Find a price of Raloxifene Hydrochloride bulk with DMF, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Rifaximin bulk with DMF, CEP offered by Cambrex Profarmaco Milano Srl

    Find a price of Salbutamol Sulphate bulk with DMF, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Sodium Picosulfate bulk with DMF, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Sotalol Hydrochloride bulk with DMF, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Sulfasalazine bulk with CEP, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Torsemide bulk with DMF, CEP offered by Cambrex Profarmaco Milano Srl

    Find a price of Triazolam bulk with DMF, JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Zolpidem Tartrate bulk with DMF, CEP offered by Cambrex Profarmaco Milano Srl

    Find a price of Ofloxacin bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Ambroxol Hydrochloride bulk with JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Amiloride Hydrochloride bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Amphetamine bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Amphetamine Aspartate bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Bromazepam bulk with CEP offered by Cambrex Profarmaco Milano Srl

    Find a price of Brotizolam bulk with JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Bupivacaine bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Buprenorphine Hydrochloride bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Calcium Oxybate bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Chlordiazepoxide bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Chlorothiazide bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Clobazam bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Clonazepam bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Cysteamine Bitartrate bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Dextroamphetamine Saccharate bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Diclofenac Epolamine bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Diltiazem Hydrochloride bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Eltrombopag bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Erlotinib Hydrochloride bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Erythromycin Lactobionate bulk with JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Etizolam bulk with JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Flunitrazepam bulk with JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Flurazepam bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Glipizide bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Hydrocodone Bitartrate bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Labetalol Hydrochloride bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Lapatinib Ditosylate bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Magnesium Oxybate bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Maraviroc bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Medazepam bulk with JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Metaproterenol Hemisulfate bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Methyclothiazide bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Methylphenidate Hydrochloride bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Midazolam Hydrochloride bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Midazolam Maleate bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Norepinephrine Bitartrate bulk with CEP offered by Cambrex Profarmaco Milano Srl

    Find a price of Olaparib bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Opium bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Ospemifene bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Oxazepam bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Pirfenidone bulk with CEP offered by Cambrex Profarmaco Milano Srl

    Find a price of Potassium Oxybate bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Rivaroxaban bulk with CEP offered by Cambrex Profarmaco Milano Srl

    Find a price of Rivastigmine Tartrate bulk with CEP offered by Cambrex Profarmaco Milano Srl

    Find a price of Sodium Oxybate bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Sulfapyridine bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Temazepam bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Teprenone bulk with JDMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Terbutaline Sulfate bulk with DMF offered by Cambrex Profarmaco Milano Srl

    Find a price of Acebutolol Hydrochloride bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Acetazolamide bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Acetohexamide bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Amoxapine bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Butalbital bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Carvedilol bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Cetirizine Dihydrochloride bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Cinoxacin bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Dextromethorphan bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Dextropropoxyphene bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Diclofenac Potassium bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Diflunisal bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Econazole Nitrate bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Fenoprofen Calcium bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Fentanyl Citrate bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Isosorbide Mononitrate bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Lamotrigine bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Levetiracetam bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Lisdexamfetamine Dimesylate bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Meclofenamic Acid bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Metoprolol Tartrate bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Naproxen bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Naproxen Sodium bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Nitazoxanide bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Nitrofurantoin bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Phentermine Hydrochloride bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Phenylephrine Hydrochloride bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Propafenone Hydrochloride bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Propoxyphene Napsylate bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Quetiapine Hemifumarate bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Salbutamol Sulphate bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Sufentanil Citrate bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of SGD-1910 bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of 4-Aminobenzoic Acid bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Acoramidis Hydrochloride bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Aficamten bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Amphetamine bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Amphetamine Aspartate bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Aripiprazole bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Aripiprazole Lauroxil bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Berotralstat Hydrochloride bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Camizestrant bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Capromorelin bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Carprofen bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Chlordiazepoxide HCl bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Chlormadinone Acetate bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Chlorpheniramine bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of CLN-081 bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Danicopan bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Dextroamphetamine Saccharate bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Dronedarone Hydrochloride bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Eletriptan Hydrobromide bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Emtricitabine bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Ensitrelvir bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Erlotinib Hydrochloride bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Fentanyl bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Ferric Maltol bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Ferric Pyrophosphate Citrate bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Filgotinib bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Flibanserin bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Flurazepam Dihydrochloride bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Furosemide bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Hydrocodone Bitartrate bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Hydromorphone Hydrochloride bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Idelalisib bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Lenalidomide bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Lifitegrast bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Linagliptin bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Methylphenidate bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Methylphenidate Hydrochloride bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Momelotinib bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Naloxegol Oxalate bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Nicotine bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Nitroglycerin bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Olanzapine bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Ondansetron Hydrochloride bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Potassium P-Aminobenzoate bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Prazepam bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Ranolazine bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Remdesivir bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Remimazolam Besylate bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Ripretinib bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Rose Bengal bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Rotigotine bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Samidorphan bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Serdexmethylphenidate bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Sibofimloc bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Sodium Thiosulfate bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Sofosbuvir bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Sulfasalazine bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Terpin bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Tesofensine bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Tolterodine Tartrate bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Trilaciclib Dihydrochloride bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Voxelotor bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of Zelnecirnon bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of UTENPANIUM CHLORIDE bulk offered by Cambrex Profarmaco Milano Srl

    Find a price of ZASOCITINIB bulk offered by Cambrex Profarmaco Milano Srl

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search